Ledger.Open graph →
SEC Form D · Amendment · filed June 27, 2022

Neurolens, Inc

Offering
$15.0M
Sold
$14.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Coppell, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

J. Andy Corley · Coppell, TXDirectorPierre Bertrand · Coppell, TXExecDavis Corley · Coppell, TXDirectorSteve Kirby · Coppell, TXDirectorTom Finzi · Coppell, TXDirectorDas Narayandas · Coppell, TXDirectorDanny Perales · Coppell, TXExecWilliam Link · Coppell, TXDirectorSarah Niyogi · SAN BRUNO, CAExecErik Volfing · Englewood Cliffs, NJExecJeffrey I. Goddard · Grand Cayman, Cayman IslandsDirectorMarlon Smith · CHICAGO, ILDirectorConnor Clancy · Dublin, IrelandDirector1031CF Portfolio 4 ST LLC · Irvine, CADirectorRobert Keough · CHICAGO, ILDirectorTaiyo Fund Management LLC · Kirkland, WADirectorChristina R. Erickson · BOSTON, MADirectorEllen Hall · BOSTON, MADirectorSimon R. Fisk · BOSTON, MADirectorEric O. Ikauniks · Boston, MADirectorThomas O. Rodes · Boston, MADirectorScott T. Ford · Little Rock, ARDirectorAshley K. Northgrave · St. Peter Port, Y7ExecChet K. Pohl · St. Peter Port, Y7Exec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗